ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,298,708 | +10.9% | 87,514 | +1.9% | 0.00% | – |
| Q1 2024 | $1,171,049 | -42.1% | 85,854 | -42.2% | 0.00% | – |
| Q1 2023 | $2,022,364 | -31.2% | 148,594 | -1.3% | 0.00% | -100.0% |
| Q4 2022 | $2,940,183 | +26.1% | 150,547 | +23.0% | 0.00% | – |
| Q3 2022 | $2,332,000 | +8.1% | 122,413 | +16.9% | 0.00% | – |
| Q2 2022 | $2,157,000 | -36.0% | 104,675 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $3,369,000 | -32.3% | 104,675 | -2.0% | 0.00% | 0.0% |
| Q4 2021 | $4,975,000 | -17.5% | 106,846 | -52.2% | 0.00% | 0.0% |
| Q3 2021 | $6,029,000 | +5.3% | 223,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,728,000 | +224.7% | 223,300 | +332.8% | 0.00% | – |
| Q1 2021 | $1,764,000 | -14.9% | 51,600 | -15.8% | 0.00% | – |
| Q4 2020 | $2,073,000 | – | 61,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |